LOOMIS SAYLES & CO L P - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$8
-11.1%
3010.0%0.00%
Q2 2023$9
-25.0%
301
-10.1%
0.00%
Q1 2023$12
-99.4%
335
+781.6%
0.00%
Q3 2022$2,000
-33.3%
38
-46.5%
0.00%
Q2 2022$3,0000.0%710.0%0.00%
Q1 2022$3,000
-62.5%
71
-68.9%
0.00%
Q3 2021$8,0002280.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders